REFERENCES;
1. Walther S, Rettinger E, Maurer HM, et al. Long-term pulmonary
function testing in pediatric bronchiolitis obliterans syndrome after
hematopoietic stem cell transplantation. Pediatric pulmonology.2020.
2. Uhlving HH, Bang CL, Christensen IJ, et al. Lung function after
allogeneic hematopoietic stem cell transplantation in children: a
longitudinal study in a population-based cohort. Biol Blood Marrow
Transplant. 2013;19(9):1348-1354.
3. Shenoy S, Gaziev J, Angelucci E, et al. Late Effects Screening
Guidelines after Hematopoietic Cell Transplantation (HCT) for
Hemoglobinopathy: Consensus Statement from the Second Pediatric Blood
and Marrow Transplant Consortium International Conference on Late
Effects after Pediatric HCT. Biol Blood Marrow Transplant.2018;24(7):1313-1321.
4. Chow EJ, Anderson L, Baker KS, et al. Late Effects Surveillance
Recommendations among Survivors of Childhood Hematopoietic Cell
Transplantation: A Children’s Oncology Group Report. Biology of
Blood and Marrow Transplantation. 2016;22(5):782-795.
5. Majhail NS, Rizzo JD, Lee SJ, et al. Recommended screening and
preventive practices for long-term survivors after hematopoietic cell
transplantation. Biol Blood Marrow Transplant.2012;18(3):348-371.
6. Shanthikumar S, Abts M, Liptzin D, et al. Surveillance for Pulmonary
Complications of Pediatric Hemopoetic Stem Cell Transplantation-An
International Survey of Current Clinical Practices. In: A52.
DIFFUSE LUNG DISEASE, ILD, DRUG INDUCED LUNG DISEASE. American Thoracic
Society; 2020:A1983-A1983.
7. Yoon JS, Chun YH, Lee JW, Chung NG, Cho B. Value of Screening
Spirometry for Early Diagnosis of Bronchiolitis Obliterans Syndrome in
Children After Allogeneic Hematopoietic Stem Cell Transplantation.Journal of pediatric hematology/oncology. 2015;37(8):e462-467.
8. Qayed M, Wang T, Hemmer MT, et al. Influence of Age on Acute and
Chronic GVHD in Children Undergoing HLA-Identical Sibling Bone Marrow
Transplantation for Acute Leukemia: Implications for Prophylaxis.Biol Blood Marrow Transplant. 2018;24(3):521-528.
9. Palmer J, Williams K, Inamoto Y, et al. Pulmonary symptoms measured
by the national institutes of health lung score predict overall
survival, nonrelapse mortality, and patient-reported outcomes in chronic
graft-versus-host disease. Biology of Blood and Marrow
Transplantation. 2014;20(3):337-344.